#AACR18 C. Kent Osborne (Baylor) awardee for extraordinary leadership and achievement in breast cancer research. Fa… https://t.co/aRIl0DnX4y
9:58am April 15th 2018 via Twitter Web Client
#AACR18 In the audio journalism category - 'Fantasy no more' on liquid biopsy Carey Goldberg WBUR/Boston https://t.co/gOrhRScE8W
9:50am April 15th 2018 via Hootsuite
#AACR18 Blog category - 'Because of Daniel' from ABC7/Washington DC reporter https://t.co/w64exszTfd
9:49am April 15th 2018 via Hootsuite
#AACR18 second awardee, Cancer's Sweet Cloak Esther Landhuis Science News https://t.co/31CKE4z1sI
9:48am April 15th 2018 via Hootsuite
#AACR18 for large journalism: Financial Times reporter David Crow https://t.co/Qr50Zxr1ZB
9:46am April 15th 2018 via Hootsuite
#AACR18 Editor of Fortune Magazine (and cancer advocate), Clifton Leaf, awarding Bidler prize in cancer journalism. Several recipients.
9:45am April 15th 2018 via Hootsuite
Japan, Singapore, Thailand represented for Asian Cancers Research team science awardees at #AACR18 https://t.co/zNllQR1ReD
9:37am April 15th 2018 via Hootsuite
Acknowledgement of Alfred Lacks: the grandson of Henrietta Lacks (origin of HeLa cells). #AACR18
9:23am April 15th 2018 via Hootsuite
#AACR18 'is at the center of a seismic shift' Margaret Foti intro. 15.5M cancer survivors in the US alone. 22K attendees from 109 countries
9:11am April 15th 2018 via Hootsuite
#AACR18 Showing highlights - from gene therapy to immunotherpay to money saved to CRISPR. Awesome individual testimony as well.
9:08am April 15th 2018 via Hootsuite
#aacr18 showing some awesome video intro! Super-wide, super-awesome. https://t.co/kD7Ej1Kovy
A2 Lianidou: Cannot expect 100%, sometimes filtration required. Next paper - compares methods, more w/filtration systems in H&N SCC #AAC
8:47am April 15th 2018 via Hootsuite
Q: Ab-free tech- filtration systems stress cells to change profile? Lianidou: At times has to be done. Corr.w/EpCAM tech not 100% #AACR18
8:46am April 15th 2018 via Hootsuite
Q: Usefulness in clinical practice? Lianidou: Where we want to go, analysis is reliable, however widespread use potential is there. #AACR18
8:45am April 15th 2018 via Hootsuite
Lianidou: 'CTCs Dx not dependable clinically'. Acknowledges many collaborators, including Christine Alix-Panabieres, Klaus Pantel #AACR18
8:42am April 15th 2018 via Hootsuite
Lianidou: Concludes with comparison between ctDNA and CTCs - adv of CTCs includes miRNA, protein analysis; can ID mets #AACR18
Lianidou: Using dx leukopheresis. 2.3mL equiv to 60mL blood. #AACR18
8:40am April 15th 2018 via Hootsuite
Lianidou: https://t.co/GvkxCYCbZU is a huge project aiming to liquid biopsy clinical eval of robust assays. Same sample across labs? #AACR18
8:39am April 15th 2018 via Hootsuite
Lianidou: Many Q's - pre-analytical, what is the analytical validation, what is the clinical validation. Many groups working #AACR18
8:38am April 15th 2018 via Hootsuite
Lianidou: What about quality control? FDA of CellSearch dep on full control from beginning to end; reviews feas., anal validation... #AACR18
Lianidou: #AACR18 https://t.co/PCoVm1BuYk Lots of technology development; combining CTCs along with EV RNA-Seq
8:37am April 15th 2018 via Hootsuite
Lianidou: SCLC analysis from Dive's group '14 https://t.co/qYVCFQ3Jeo #AACR18
8:36am April 15th 2018 via Hootsuite
Lianidou: #AACR18 Microfluidic western blotting from sc (!) https://t.co/Aj0tf5jLUd
8:34am April 15th 2018 via Hootsuite
Lianidou: sc CNV from Silicon Biosystems '18 ref https://t.co/DW6IHS5MZV #AACR18
8:33am April 15th 2018 via Hootsuite
Lianidou: #AACR18 In '12 ref https://t.co/EVyCixcGM8 shows sc heterogeneity, diversity
8:31am April 15th 2018 via Hootsuite
Lianidou: Presenting four posters here - ESR1 methylation, sample storage for liquid biopsy. #AACR18 Moving toward sc analysis
8:30am April 15th 2018 via Hootsuite
Lianidou: #AACR18 Latest- CTCs from CellSearch cartridges, looked at ESR1 methylation status. Correl. to PFS, OS https://t.co/Mmoj9Nd507
8:29am April 15th 2018 via Hootsuite
Lianidou: For high risk PC - multiplex GEx '18 Clin Chem https://t.co/ZrBVhfGpCP #AACR18
8:28am April 15th 2018 via Hootsuite
Lianidou: Prognostic sig of PD-L1 in head and neck SCC '17 ref https://t.co/EVTSqdKY6X #AACR18
8:25am April 15th 2018 via Hootsuite
Lianidou: OS in early BC, dev multiplex RT-PCR '11 https://t.co/wUalyD22b0 no preampl to retain quant info #AACR18
8:24am April 15th 2018 via Hootsuite
Lianidou: Shows lab photo - all female - her work focuses on GEx '08 ref https://t.co/kGdqywnhC9 #AACR18
8:23am April 15th 2018 via Hootsuite
Lianidou: Ovarian - not many groups, GEx mainly. '17 ref https://t.co/Qt1TOuzE3N #AACR18
8:22am April 15th 2018 via Hootsuite
Lianidou: PD-1 and PD-L1 in NSCLC, shows nice images from '18 ref https://t.co/06rsFAHywt #AACR18
8:21am April 15th 2018 via Hootsuite
Lianidou: #AACR18 ALK copy number in CTCs related to prog-free surv in NSCLC https://t.co/H7WrijmITt
8:20am April 15th 2018 via Hootsuite
Lianidou: #AACR18 NSCLC: a 'tremendous amt of new knowledge'; EGFR '08, NOTCH-1 '16; PD-L1 in CTCs from LuCa.
8:19am April 15th 2018 via Hootsuite
Lianidou: #AACR18 '16 https://t.co/m3Z4U7bZrM combines CellSearch , an in vivo CellCollector, EPISPOT for non mPC
8:18am April 15th 2018 via Hootsuite
Lianidou: #AACR18 AR-V7's usefulness in mPC '17 ref https://t.co/cOCW8Wt9sj
8:16am April 15th 2018 via Hootsuite
Lianidou: For prostate cancer: metastatic castration resist prostate ca: CellSearch study. AR-V7 derived from CTC: for mPC #AACR18
8:15am April 15th 2018 via Hootsuite
Lianidou: OS worse and DFS worse w/CTC counts. Metanalysis (21 studies) show prognostic value. (in press) #AACR18
8:14am April 15th 2018 via Hootsuite
Lianidou: RNA based gene exp - AR, others genes; Rossi CCR '17 https://t.co/rAaSHWGrbP both ctDNA and CTC (CellSearch, Guardant) #AACR18
8:12am April 15th 2018 via Hootsuite
Lianidou: ESR1 mutations detected - '17 ref https://t.co/4zNg4znFKM impt for mBC #AACR18
8:10am April 15th 2018 via Hootsuite
Lianidou: Det of therapeutic targets - HER2, shown by Pantel and others. Software recent PLOS One https://t.co/Jtoukp5lwR to detect #AACR18
8:08am April 15th 2018 via Hootsuite
Lianidou: In Br ca - '04 NEJM https://t.co/kuwkU5pg3P 'seminal paper' for CellSearch, assoc'd with survival oin mBC #AACR18
8:07am April 15th 2018 via Hootsuite
Lianidou: #AACR18 EMT occurs in CTC Shows fig from '11 ref https://t.co/y22U6PDcus
8:05am April 15th 2018 via Hootsuite
Lianidou: #AACR18 Clin Chem '11 https://t.co/tZYtQNepLy EMT plays impt role in CTC isol and detection. EpCAM, CK on left, Vimentin on right
Lianidou: From size- or affinity-based, to physical characteristics. Imaging or molecular: complementary methods #AACR18
8:03am April 15th 2018 via Hootsuite
Lianidou: CTCs, ctDNA, and circ miRNAs. More than 100 years ago history; PNAS 1988 ref; many methods of selection #AACR18
8:02am April 15th 2018 via Hootsuite
Lianidou: Rapidly expanding liquid biopsy fld; addresses major needs like Dx, prognosis, detection of resid disease, risk of relapse #AACR18
8:00am April 15th 2018 via Hootsuite
Evi Lianidou (Athens GR) CTC characterization and applications #AACR18
7:59am April 15th 2018 via Hootsuite
@PeerView You are welcome - I enjoyed last night's presentation very much! Dale
7:59am April 15th 2018 via Hootsuite in reply to PeerView